A groundbreaking milestone has been reached in the fight against malaria. Novartis announced today that its revolutionary medication has received regulatory approval to address malaria in newborns and infants, signaling a major leap forward in global health. This cutting-edge pharmaceutical will now be available to countries where malaria is most